CapsoVision (CV) Interest Coverage Ratio: History & Chart

CapsoVision, Inc.(CV)

Medical - Devices · Saratoga, CA

$6.50-0.08 (-1.29%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About CapsoVision, Inc.

CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. The company serves gastrointestinal medical practices, clinics, and hospitals. It sells its products to distributor customers who resell products. The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016. CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.

Saratoga, CA

99 employees

capsovision.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Kang-Huai Wang

View full financials

NAME	MARKET CAP	INTEREST COVERAGE RATIO	TTM	3Y	5Y
CapsoVision, Inc. (CV)	$324.76M	N/A	N/A	N/A	N/A
Avita Medical Inc. (RCEL)vs ›	$322.71M	-8.50x	39.51x	19.80x	13.45x
Sanara MedTech Inc. (SMTI)vs ›	$321.76M	1.35x	1.35x	1.35x	1.35x
Cabaletta Bio, Inc. (CABA)vs ›	$329.37M	-85.95x	N/A	N/A	N/A
ClearPoint Neuro, Inc. (CLPT)vs ›	$330.19M	-10.12x	N/A	N/A	N/A
C4 Therapeutics, Inc. (CCCC)vs ›	$318.43M	N/A	N/A	N/A	N/A
Agenus Inc. (AGEN)vs ›	$311.90M	-0.37x	0.39x	0.39x	0.39x
Benitec Biopharma Inc. (BNTC)vs ›	$309.19M	N/A	12.71x	12.71x	12.71x
Relmada Therapeutics, Inc. (RLMD)vs ›	$344.04M	N/A	N/A	N/A	N/A
Turn Therapeutics Inc. (TTRX)vs ›	$346.73M	N/A	N/A	N/A	N/A

NAME

MARKET CAP

INTEREST COVERAGE RATIO

TTM

CapsoVision, Inc. (CV)

$324.76M

N/A

Avita Medical Inc. (RCEL)vs ›

$322.71M

-8.50x

39.51x

19.80x